This is of particular interest for disease models in which IgG3 acts as a marker of exposure, such as in protozoan infections [12-14] as well as for the mounting evidence that blood-stage specific IgG3 may be associated with protective immunity against malaria depending on the target antigen [15-17]. This evidence concerns the gene IGHG3 and malaria.